Bevacizumab 25 mg/ml Concentrate for solution for infusion

Bevasan contains the active substance bevacizumab, which is a humanized monoclonal antibody (a type of protein that is normally made by the immune system to help defend the body from infection and cancer). Bevasan is used for the treatment of adult patients with Advanced cancer in the large bowel, i.e., in the colon or rectum. Metastatic breast cancer. Advanced non-small cell lung cancer. Advanced kidney cancer. Advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer.

Disclaimer: Items covered by valid patents not offered or supplied for commercial sale. Patent position should be verified by the buyer in the territory :تنويه المستحضرات المشمولة ببراءات اختراع مسجلة، غير معروضة ولا يتم تزويدها من قبل الشركة يجب التحقق من صحة وتسجيل براءة الاختراع من قبل المشتري في بلده